Just been diagnosed with prostrate cancer
Posted , 19 users are following.
I am 50 yr old reasonably fit and healthy or at least I thought I was.
My blood test revealed PSA level @ 6.2 which later reduced to 5.8 on my second test , I was sent for a biopsy where the doc told me my prostrate felt enlarged but didn't feel abnormal , unfortunately my results later revealed I have localised prostrate cancer . When the doctor revealed the news yesterday I was in total shock but now realise I am one of the lucky ones as my cancer appears to be none aggressive type, only one of the twelve biopsy samples revealed a small volume of cancer with a Gleason score of 6 which apparently is low.
My worry now is to decide to what to do next regarding treatment.
Do I sit and watch and wait or would anyone out there with a similar story advise otherwise., I am thinking about Prostate Seed Brachytherapy treatment but don't know a lot about the risks after or what the success rate is. At present, besides going to the loo more often my life hasn't been too affected.
Can anyone advise what to do
I have a choice to watch and wait or have radiotherapy ,, my dilemma is what if it spreads . Advice would be greatly appreciated
Yours worried S,,
0 likes, 129 replies
aksns61 JoeLucky
Posted
The following official statement was issued on September 15 by the American Society for Radiation Oncology (ASTRO):ASTRO ENCOURAGES PROSTATE CANCER PATIENTS TO WEIGH LONG-TERM IMPACT OF TREATMENT OPTIONS WITH THEIR DOCTORS
In light of the findings from the Prostate Testing for Cancer and Treatment (ProtecT) trial published in the New England Journal of Medicine, the American Society for Radiation Oncology (ASTRO) would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study. Their paper emphasizes the importance of joint decision making between prostate cancer patients and their physicians when weighing treatment options for early stage disease. Findings from the ProtecT trial can help patients understand the full range of approaches to manage their disease, including the risks and benefits of active monitoring versus early treatment with radiation therapy (RT) or surgery.
Ten-year findings from the trial indicate that for men with early stage prostate cancer, there is no difference in mortality rates following active monitoring, surgery or RT, and moreover, that cancer-specific deaths at ten years following diagnosis averaged only one percent for all men enrolled in the trial.
Growth of the cancer outside of the prostate did vary between monitoring and treatment groups. Rates of both regional spread and distant metastases were significantly higher for men who were monitored rather than treated for their early stage disease. Progression did not vary, however, between the surgery and RT groups, although patients in the trial reported different side effects with each modality.
“These findings underscore the essential role of dialogue in treatment selection,” said ASTRO President David C. Beyer, MD, FASTRO. “Men with prostate cancer are all different, and the relative costs and benefits associated with the multiple options to treat it can vary substantially between individuals. The best treatment decisions for prostate cancer, or any cancer, take into consideration the specifics of each individual patient’s disease, expectations and preferences. These options can be confusing, and patients should always make these decisions after consultation with a radiation oncologist and urologist”
ASTRO, the American Urological Association (AUA) and the American Society for Clinical Oncology (ASCO) are currently developing updated guidelines for the management of clinically localized prostate cancer. The recommendations, which update a 2007 collaborative guideline issued by the societies, are scheduled for publication in mid-2017.
The “New” Prostate Cancer InfoLink considers this statement to be entirely appropriate based on the data, and we are delighted to see that ASTRO and the American Urological Association (AUA) will be issuing a badly needed, joint update to their guidelines on the management of clinically localized prostate cancer as a consequence! As yet we have seen no formal statement from the AUA.
ES28567 aksns61
Posted
Great post aksns61.
That's the kind of info that we need on this forum!
Tybeeman ES28567
Posted
Key words "early stage disease"
barney34567 Tybeeman
Posted
What is "early stage"?
Is a Gleason 3+3 believed to be contained in the prostate considered "early stage"? What about a Gleason 4+5 believed to be contained in the prostate. Is that considered "early stage"?
Roger2Dodger barney34567
Posted
My Gleason score was 4+3 =7. This score is considered intermediate. I consider
Tybeeman barney34567
Posted
alfred5 barney34567
Posted
Roger2Dodger barney34567
Posted
Posted my reply inadvertentl, before finishing.
A 9 Gleason score is not good in my opinion. I would not think early stage. I am not a Doctor or expert, JMO. My Gleason score 4+3 was considered intermediate cancer. However, after my Urologist sent my biopsy remains for Genetic testing the results were non aggressive, which the Gleason score of 7 was contradictory to the Genetic testing which put my cancer in the nonaggresive range. Like you said, there is no one treatment for PCA and fuction of:
the aggressiveness of the PCa AND
the age of the man
That is why I chose active surivilance
I will be reevaluated in December, so, my thoughts on which cancer is early stage has lots of determine factors. .
I would like to read others opinion.
Tybeeman alfred5
Posted
The lowest score is 2. They really don’t start treating it till it is a 6. So you are right that 6 is the lowest score that they will start treatment. 2 to 5 they wait and see. But even then if a man is up in his 80's they may keep watching it till it gets higher.
ES28567 Tybeeman
Posted
That is correct. Some don't even really consider it cancer until it hits 6. In my case, (3+3) it was low but because of the location there was more potential for it to spread and therefore prudent to take action beyond AS.
alfred5 Tybeeman
Posted
barney34567 Roger2Dodger
Posted
barney34567 Tybeeman
Posted
Honestly, from what I read in the. Last few months I think a 3+3 could be monitored for a while.
of course the question is " how long is a while"
barney34567 alfred5
Posted
so putting aside the Gleason score, would you treat a T2b with surgery or radiation or just monitor it?
barney34567 Roger2Dodger
Posted
that is why I wasted no time to have my Gleason 9 robotically removed
barney34567 Roger2Dodger
Posted
as I am sure you know, a biopsy is a very good estimate of the PCa, but only its removal gives a definitive pathology.
i was always worried that a biopsy can under or overestimate the PCa.
Roger2Dodger barney34567
Posted
aksns61 Roger2Dodger
Posted
barney34567 Roger2Dodger
Posted
Further to Aksn's comments, when it comes to possibly undergoing treatment, find one urologist you trust and be guided by him.
Roger2Dodger aksns61
Posted
I do appreciate your reply to my status. To clarify my treatment decisions, My medical staff was very much involved in all my treatment decisions.
Roger2Dodger barney34567
Posted
barney,
Just to reinterate my treatment decision. My Urologist made the decision that I go on active surveillance, I was hesitiant at first, but Along with my family, wife and 4 daughters agreed after the rest results came back from Myriad Genetics, (Prolaris) . My family and I have decided to trust his decision. but, I am a little skeptical of trusting any one, but thats just me.
This was the deciding factor in my treatment decision.
The New genetic tests make it easier to identify aggressive early stage cancers. Prolaris, which tests for 46 genes, has been shown in studies to accurately predict the aggressiveness of a patient's prostate tumour in conjunction with Gleason scores and PSA tests. My tests came back in the non aggresive range.
barney34567 Roger2Dodger
Posted
i like you would be skeptical about AS.
how reliable is the genetic test?
i am not sure I would go that route with a Gleason 7 which is really the best estimate.
only when a prostate is removed can one tell for sure the Gleason score, which may be different to 7
what tumor stage is it?
Roger2Dodger barney34567
Posted
I called Myriad Laboratories (Prolaris ) and had a long discussion with a lab tech. And with my Prolaris score, he also agreed with my Urologist, that I was a candidate for AS.
I feel like I have time to make a definite treatment decision after my next evaluation.
Did I mention I just turned 76 years old. If I had been 15 -20 years. Younger. No doubt, I would have chose treatment, My thoughts are, if I can forgo evasive treatment for what years I have left is a no brainer. No one is promised tomorrow.
barney34567 Roger2Dodger
Posted
Ok, so now I know you are 76. And the stage is T1.
in your position I would do as you're doing: AS, even without the Prolaris test.
Roger2Dodger barney34567
Posted
Yes the stage is T1c, meaning cancer found via a needle biopsy and biopsy initiated by abnormal PSA.
There is TIa , TIb and T1c . Either 3 means cancer is present.
barney34567 Roger2Dodger
Posted